Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 11 - Drugs for disorders of the respiratory system
Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767)
06/1999
06/10/1999WO1999028493A2 Method for identifying inhibitors of g-protein coupled receptor hibef51
06/10/1999WO1999028475A2 Chlamydia trachomatis genomic sequence and polypeptides, fragments thereof and uses thereof, in particular for the diagnosis, prevention and treatment of infection
06/10/1999WO1999028342A2 Low-voltage activated calcium channel compositions and methods
06/10/1999WO1999028310A1 Pseudopolymorphic forms of 2-[2-[4-[bis (4-fluorophenyl) methyl]-1-piperazinyl] ethoxy]acetic acid dihydrochloride
06/10/1999WO1999028307A1 Alicyclic acylated heterocyclic derivatives
06/10/1999WO1999028304A2 Pdgf receptor kinase inhibitory compounds, their preparation and compositions
06/10/1999WO1999027941A1 Oral antioxidant preparation comprising selenium and reduced glutathione
06/10/1999WO1999027927A1 Synergistic antimicrobial compositions
06/10/1999WO1999027924A2 Fatty acid uninterrupted by a methylene as anti-inflammatory agents in superficial tissues of mammals
06/10/1999WO1999027920A2 Use of phospholipids for the manufacture of a medicament for the treatment of asthma
06/10/1999WO1999004765A3 Pharmaceutical compositions containing an effervescent acid-base couple
06/10/1999CA2312811A1 Synergistic antimicrobial compositions
06/10/1999CA2312770A1 Alicyclic acylated heterocyclic derivatives
06/10/1999CA2312749A1 Pdgf receptor kinase inhibitory compounds and compositions, method for synthesis of same and use of same for treatment of proliferate disorders
06/10/1999CA2312464A1 Oral antioxidant preparation comprising selenium and reduced glutathione
06/10/1999CA2312195A1 Low-voltage activated calcium channel compositions and methods
06/10/1999CA2309228A1 Chlamydia trachomatis genomic sequence and polypeptides, fragments thereof and uses thereof, in particular for the diagnosis, prevention and treatment of infection
06/09/1999EP0921124A1 Benzothiophene derivatives useful in therapy
06/09/1999EP0920867A1 Pyrido[2,3-a]pyrazine derivatives as PDE-IV and TNF inhibitors
06/09/1999EP0920865A1 Pharmaceutical compositions containing Norastemizole
06/09/1999EP0920425A1 Substituted 4-(1h-benzimidazol-2-yl-amino)piperidines useful for the treatment of allergic diseases
06/09/1999EP0920417A1 Il-8 receptor antagonists
06/09/1999EP0920324A2 Pure biologically active colistin, its components and a colistin formulation for treatment of pulmonary infections
06/09/1999EP0920315A1 Treatment of upper airway allergic responses with a combination of histamine receptor antagonists
06/09/1999EP0920306A2 Chemokine receptor antagonists and methods of use therefor
06/09/1999EP0920253A1 Il-8 receptor antagonists
06/09/1999EP0751932B1 Vitamin-d amide derivatives
06/09/1999CN1219172A Novel benzo-1,3-dioxolyl- and benzofuranyl substituted pyrrolidine derivatives as endothelin antagonists
06/09/1999CN1219171A Benzofuran carboxamides and their therapeutic use
06/09/1999CN1218802A Substituted isoquinoline-3-formamides compounds, its preparing method and its use as medicine
06/09/1999CN1218801A Tri-substituted imidazoles, and process of their preparation and using the same and having their pharmic composition
06/09/1999CN1218669A Tuberculosis medicine
06/08/1999US5910574 Human trk receptors and neurotrophic factor inhibitors
06/08/1999US5910499 Leukotriene production inhibiting action and antihistaminic action; oral administration
06/08/1999US5910437 Ligated d-protein of formula r-l-r' where r and r' are peptides and l is linking group of thiol ester or selenol ester; for production of chirally pure chemicals and drugs; production of racemic crystals; prolonged half-life in body
06/08/1999US5910430 Isolated nucleic acid encoding G-protein coupled receptor (HTADX50)
06/08/1999CA2255165A1 Benzothiophene derivatives useful in therapy
06/08/1999CA2242308A1 Novel compounds
06/03/1999WO1999027103A1 Mammalian cytokine-like polypeptide-10
06/03/1999WO1999027098A2 A-33 related antigens and their pharmacological uses
06/03/1999WO1999026945A1 1,3,4-THIADIAZOLES AND 1,3,4-OXADIAZOLES AS αvβ3 ANTAGONISTS
06/03/1999WO1999026942A1 5-(2-imidazolinylamino)-benzimidazole derivatives, their preparation and their use as .alpha.-adrenoceptor agonists with improved metabolic stability
06/03/1999WO1999026924A1 Substituted oximes as neurokinin antagonists
06/03/1999WO1999026921A1 SUBSTITUTED β-ALANINE DERIVATIVES AS CELL ADHESION INHIBITORS
06/03/1999WO1999026909A2 Alpha-hydroxy, -amino and -fluoro derivatives of beta-sulphonyl hydroxamic acids as matrix metalloproteinases inhibitors
06/03/1999WO1999026651A1 ribH
06/03/1999WO1999026650A1 ribB
06/03/1999WO1999026646A1 ribA
06/03/1999WO1999026628A1 Use of substituted 11-phenyl-dibenzazepine compounds for the treatment or prevention of sickle cell disease, inflammatory diseases characterized by abnormal cell proliferation, diarrhea and scour
06/03/1999WO1999026616A1 Benzenesulfonamide inhibitors of pde-iv and their therapeutic use
06/03/1999WO1999026615A1 Cyclic amino acid derivatives as cell adhesion inhibitors
06/03/1999WO1999026604A2 Selected c10 perfluorinated hydrocarbons for liquid ventilation and artificial blood
06/03/1999WO1999018939A9 Methods of treating capsules and dry, powdered pharmaceutical formulations
06/03/1999WO1999015656A3 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders
06/03/1999WO1999014242A3 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders
06/03/1999WO1999012566A9 HUMANIZED ANTIBODIES TO HUMAN gp39, COMPOSITIONS CONTAINING AND THERAPEUTIC USE THEREOF
06/03/1999WO1999011275A3 Use of immunostimulatory oligonucleotides for preventing or reducing antigen-stimulated, granulocyte-mediated inflammation
06/03/1999WO1999010312B1 N-alkanoylphenylalanine derivatives
06/03/1999WO1999007729A3 Peptides having potassium channel opener activity
06/03/1999CA2312000A1 Mammalian cytokine-like polypeptide-10
06/03/1999CA2310773A1 Use of substituted 11-phenyl-dibenzazepine compounds for the treatment or prevention of sickle cell disease, inflammatory diseases characterized by abnormal cell proliferation, diarrhea and scour
06/03/1999CA2310401A1 Alpha-hydroxy, -amino and -halo derivatives of beta-sulfone hydroxamates as matrix metalloproteinase inhibitors
06/03/1999CA2309358A1 A-33 related antigens and their pharmacological uses
06/03/1999CA2309341A1 Substituted .beta.-alanine derivatives as cell adhesion inhibitors
06/03/1999CA2309338A1 Cyclic amino acid derivatives as cell adhesion inhibitors
06/03/1999CA2309204A1 1,3,4-thiadiazoles and 1,3,4-oxadiazoles as .alpha.v.beta.3 antagonists
06/02/1999EP0919550A1 Pseudopolymorphic forms of 2-2-4-bis(4-fluorophenyl)methyl-1-piperazinyl-ethoxy acetic acid dihydrochloride
06/02/1999EP0919544A1 Compounds useful for treating allergic and inflammatory diseases
06/02/1999EP0919230A1 NMIFA's as anti-inflammatory agents in superficial mammal tissues
06/02/1999EP0918792A1 Dipeptide benzamidine as a kininogenase inhibitor
06/02/1999EP0918760A1 Biologically active benzothiazolone ethanamines
06/02/1999EP0918746A1 Immunotherapeutic agents and their use in the reduction of cytokine levels
06/02/1999EP0918540A1 Intradermal bovine polynucleotide vaccine
06/02/1999EP0918461A1 Methods of treating asthma with o-desulfated heparin
06/02/1999EP0625138B1 Novel amidine derivatives, their preparation and their use as medicaments with ltb4 antagonistic effect
06/02/1999CN1218459A 2-(3H)-oxazolene derivatives and their use as cox-2 inhibitors
06/02/1999CN1218401A Treatment of asthma and airway diseases
06/02/1999CN1218395A Buccal delivery system
06/02/1999CN1218368A Method for treating common cold or allergic rhinitis
06/02/1999CN1218047A Novel imidazolidine derivatives, their preparation, their use and pharmaceutical preparations comprising them
06/02/1999CN1217938A Series of instant powder for common cold
06/02/1999CN1217926A Chinese medicinal composition for nascsinusitis
06/01/1999US5908858 1,2-diphenylpyrrole derivatives, their preparation and their therapeutic uses
06/01/1999US5908839 Administering mixture of tyrosine kinase inhibitor and amino sterol
06/01/1999CA1340567C Heterocyclic amide derivatives
05/1999
05/27/1999WO1999025714A1 Piperidinylaminomethyl trifluoromethyl cyclic ether compounds as substance p antagonists
05/27/1999WO1999025710A1 Imidazole derivatives, preparation and therapeutic application thereof
05/27/1999WO1999025701A1 NOVEL HETEROCYCLICALLY SUBSTITUTED α-HYDROXYCARBOXLIC ACID DERIVATIVES, METHOD FOR PRODUCING THE SAME AND THEIR USE AS ENDOTHELIN RECEPTOR ANTAGONISTS
05/27/1999WO1999025686A1 Cyclic amine derivatives and their use as drugs
05/27/1999WO1999025372A1 Small peptides and methods for treatment of asthma and inflammation
05/27/1999WO1999025359A1 New composition of matter
05/27/1999WO1999025357A1 USE OF 9-DEOXY-2', 9-α-METHANO-3- OXA-4,5,6- TRINOR-3, 7-(1',3'-INTERPHENYLENE) -13,14-DIHYDRO- PROSTAGLANDIN F1 TO TREAT PERIPHERAL VASCULAR DISEASE
05/27/1999WO1999025356A1 Use of mirtazapine for treating sleep apneas
05/27/1999WO1999025338A1 Pharmaceutical composition containing zafirlukast
05/27/1999WO1999018952B1 UPREGULATION OF TYPE III ENDOTHELIAL CELL NITRIC OXIDE SYNTHASE BY HMG-CoA REDUCTASE INHIBITORS
05/27/1999WO1999018099B1 Aryl thiophene derivatives as pde iv inhibitors
05/27/1999WO1999014346A3 SENSE mRNA THERAPY
05/27/1999WO1999012933A3 Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase
05/27/1999CA2309744A1 Use of mirtazapine for treating sleep apneas
05/27/1999CA2308746A1 Novel heterocyclically substituted .alpha.-hydroxycarboxylic acid derivatives, method for producing the same and their use as endothelin receptor_antagonists
1 ... 771 772 773 774 775 776 777 778 779 780 781 782 783 784 785 786 787 788 789 790 791 ... 878